RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone
Icaria-MM study
Houghton, K., Dimopoulos, M. A., Lin, P., Guillonneau, S., Bury, D., Attal, M., Richardson, P. G., & Delforge, M. (2019). Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone: Icaria-MM study. Blood, 134(Supplement_1), 1850. https://doi.org/10.1182/blood-2019-128220